Garrick P. Smith

1.3k total citations
23 papers, 865 citations indexed

About

Garrick P. Smith is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Garrick P. Smith has authored 23 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Garrick P. Smith's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). Garrick P. Smith is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). Garrick P. Smith collaborates with scholars based in Denmark, United Kingdom and United States. Garrick P. Smith's co-authors include Kristen Frederiksen, Thomas Ruhland, Arne Mørk, Morten Jørgensen, Søren Nielsen, Sandra Hogg, Huailing Zhong, Benny Bang‐Andersen, Tine B. Stensbøl and Klaus Gjervig Jensen and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Cerebral Cortex.

In The Last Decade

Garrick P. Smith

23 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garrick P. Smith Denmark 15 326 282 232 155 153 23 865
P. Malherbe Switzerland 11 555 1.7× 481 1.7× 80 0.3× 88 0.6× 48 0.3× 15 973
Judit Sóvágó Sweden 18 400 1.2× 730 2.6× 293 1.3× 101 0.7× 41 0.3× 34 1.5k
Liliana P. Montezinho Denmark 12 272 0.8× 271 1.0× 142 0.6× 191 1.2× 23 0.2× 18 747
Deborah K. Hyslop United States 12 324 1.0× 515 1.8× 142 0.6× 101 0.7× 93 0.6× 19 900
Ian A. Pullar United Kingdom 21 469 1.4× 592 2.1× 148 0.6× 117 0.8× 177 1.2× 38 1.1k
Cornelia Dorner‐Ciossek Germany 19 412 1.3× 220 0.8× 205 0.9× 57 0.4× 78 0.5× 41 817
Orlando Ghirardi Italy 26 460 1.4× 420 1.5× 128 0.6× 98 0.6× 99 0.6× 45 1.4k
M. N. Subhash India 18 250 0.8× 318 1.1× 112 0.5× 82 0.5× 91 0.6× 46 870
Alan Robertson United Kingdom 22 473 1.5× 301 1.1× 241 1.0× 59 0.4× 425 2.8× 33 1.5k
M. Amin Khan United States 13 205 0.6× 185 0.7× 149 0.6× 44 0.3× 33 0.2× 16 579

Countries citing papers authored by Garrick P. Smith

Since Specialization
Citations

This map shows the geographic impact of Garrick P. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garrick P. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garrick P. Smith more than expected).

Fields of papers citing papers by Garrick P. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garrick P. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garrick P. Smith. The network helps show where Garrick P. Smith may publish in the future.

Co-authorship network of co-authors of Garrick P. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Garrick P. Smith. A scholar is included among the top collaborators of Garrick P. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garrick P. Smith. Garrick P. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Garrick P., et al.. (2024). Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases. Cellular and Molecular Life Sciences. 81(1). 3 indexed citations
2.
Williamson, D.S., Garrick P. Smith, Lassina Badolo, et al.. (2021). Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. Journal of Medicinal Chemistry. 64(14). 10312–10332. 23 indexed citations
3.
Sotty, Florence, Poul Henning Jensen, Lassina Badolo, et al.. (2019). Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and Implications. eNeuro. 6(6). ENEURO.0453–18.2019. 4 indexed citations
4.
Christensen, Kenneth Vielsted, Lassina Badolo, Garrick P. Smith, et al.. (2018). Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation. Neurobiology of Disease. 116. 13–27. 19 indexed citations
5.
Wegener, Karen Malene, Steen Larsen, Lassina Badolo, et al.. (2018). PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats. Toxicology. 395. 15–22. 42 indexed citations
6.
Smith, Garrick P., Lassina Badolo, I‐Jen Chen, et al.. (2017). The design and SAR of a novel series of 2-aminopyridine based LRRK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(18). 4500–4505. 14 indexed citations
7.
Christensen, Kenneth Vielsted, Garrick P. Smith, & D.S. Williamson. (2017). Development of LRRK2 Inhibitors for the Treatment of Parkinson's Disease. Progress in medicinal chemistry. 56. 37–80. 15 indexed citations
8.
Thirstrup, Kenneth, Justus C. Dächsel, Felix Oppermann, et al.. (2017). Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells. Scientific Reports. 7(1). 10300–10300. 73 indexed citations
9.
Johansen, Jens Leander, et al.. (2016). Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP+ and Rotenone Toxicity. Frontiers in Cellular Neuroscience. 10. 164–164. 18 indexed citations
10.
Sason, Hagit, Garrick P. Smith, Eitan S Kaplan, et al.. (2016). Asc-1 Transporter Regulation of Synaptic Activity via the Tonic Release of d-Serine in the Forebrain. Cerebral Cortex. 27(2). bhv350–bhv350. 58 indexed citations
11.
Wang, Jia, et al.. (2015). High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139. Acta Pharmacologica Sinica. 36(7). 874–878. 24 indexed citations
12.
Bang‐Andersen, Benny, Thomas Ruhland, Morten Jørgensen, et al.. (2011). Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder. Journal of Medicinal Chemistry. 54(9). 3206–3221. 355 indexed citations
13.
Redrobe, John P., Lisbeth Elster, Kristen Frederiksen, et al.. (2011). Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats. Psychopharmacology. 221(3). 451–468. 50 indexed citations
14.
Smith, Garrick P., et al.. (2011). Synthesis of N-alkylated amino acids using fluorous-tagged hydroxylamines. Tetrahedron. 67(29). 5261–5267. 7 indexed citations
15.
Smith, Garrick P., et al.. (2010). Synthesis and Application of a New Fluorous‐Tagged Ammonia Equivalent. Chemistry - A European Journal. 16(15). 4557–4566. 14 indexed citations
16.
Smith, Garrick P., et al.. (2006). The synthesis and SAR of 2-arylsulfanylphenyl-1-oxyalkylamino acids as GlyT-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(15). 3981–3984. 38 indexed citations
17.
Smith, Garrick P., Thomas Ruhland, Kim Andersen, et al.. (2004). The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(15). 4027–4030. 23 indexed citations
18.
Brundish, Derek E., Peter D. Kane, Mark E. McDonnell, et al.. (1999). Design and Synthesis of Thrombin Inhibitors:  Analogues of MD-805 with Reduced Stereogenicity and Improved Potency. Journal of Medicinal Chemistry. 42(22). 4584–4603. 28 indexed citations
19.
Jung, Michel J., et al.. (1993). Synthesis of analogues of squalene as potential anti-fungal agents. Journal of the Chemical Society Perkin Transactions 1. 3073–3073. 5 indexed citations
20.
Mann, John & Garrick P. Smith. (1991). Synthesis of potential inhibitors of squalene epoxidase. Journal of the Chemical Society Perkin Transactions 1. 2884–2884. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Malherbe Breakdown of academic impact, for papers by Judit Sóvágó Breakdown of academic impact, for papers by Liliana P. Montezinho Breakdown of academic impact, for papers by Deborah K. Hyslop Breakdown of academic impact, for papers by Ian A. Pullar Breakdown of academic impact, for papers by Cornelia Dorner‐Ciossek Breakdown of academic impact, for papers by Orlando Ghirardi Breakdown of academic impact, for papers by M. N. Subhash Breakdown of academic impact, for papers by Alan Robertson Breakdown of academic impact, for papers by M. Amin Khan
Rankless by CCL
2026